Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-107334
Filing Date
2025-08-12
Accepted
2025-08-12 16:15:33
Documents
64
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ck0001534133-20250630.htm   iXBRL 10-Q 3195959
2 EX-10.2 ck0001534133-ex10_2.htm EX-10.2 26491
3 EX-31.1 ck0001534133-ex31_1.htm EX-31.1 16518
4 EX-31.2 ck0001534133-ex31_2.htm EX-31.2 16543
5 EX-32.1 ck0001534133-ex32_1.htm EX-32.1 10320
6 EX-32.2 ck0001534133-ex32_2.htm EX-32.2 9608
  Complete submission text file 0000950170-25-107334.txt   11385695

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ck0001534133-20250630.xsd EX-101.SCH 1301376
67 EXTRACTED XBRL INSTANCE DOCUMENT ck0001534133-20250630_htm.xml XML 2284842
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39538 | Film No.: 251206894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)